Navigation Links
UCL and Novo Nordisk partner to take action against urban diabetes
Date:3/28/2014

UCL is partnering with Novo Nordisk and the Steno Diabetes Center a world leading institution in diabetes care and prevention to launch the Cities Changing Diabetes initiative, an ambitious new partnership programme to fight urban diabetes.

The Cities Changing Diabetes programme will initially launch in Mexico City, with cities in North America, Europe and Asia to follow.

The aim of the programme is to map where the problem of diabetes is most acute, share solutions and drive concrete action to fight it in cities around the world. To do so, the partners will work with a range of additional local partners including healthcare professionals, city authorities, urban planners, businesses, academics and community leaders, amongst others.

Following the programme's initial discovery phase, UCL will work with Novo Nordisk and the Steno Diabetes Center and a range of policy makers and experts drawn from health authorities, the private sector and the volunteer sector to announce multi-year action plans detailing the commitments of its campaign in each of the cities that will be part of the programme.

UCL's contribution will be led by Professor David Napier, Professor of Medical Anthropology in the UCL Department of Anthropology. He will be leading a team of research staff who will gather data on the ground about diabetes epidemiology in urban environments. His involvement was facilitated by UCL Consultants, an independent company wholly owned by UCL and one of the UK's leading providers of academic consultancy services.

The rise of diabetes is one of the world's most serious health challenges. By 2030, it is estimated that more than half a billion people will suffer from diabetes. Today, nearly two thirds of everyone with diabetes live in cities, and those who move to cities are significantly more likely to develop diabetes than those who remain in rural settings.

From rising wealth and increasing consumption, to more sedentary lifestyles and inequality of access to health care, urban living presents a major challenge to health and has become one of the key drivers behind the acceleration of global diabetes.

"The global diabetes epidemic is an emergency in slow motion," says Lars Rebien Srensen, chief executive officer, Novo Nordisk. "While there are many factors fuelling the growth trajectory of diabetes, the most striking contributor is urbanisation and the growth of cities. The 'Cities Changing Diabetes' programme is our call to arms for people around the world to work together to tackle this for the long-term."

David Napier, Professor of Medical Anthropology in the UCL Department of Anthropology, said:

"We are delighted to bring our expertise to bear through supporting research that will underpin Cities Changing Diabetes. We will be working on the ground to gather data across the globe, setting a baseline to the challenge of diabetes, and acting as a platform for future action. Working with Cities Changing Diabetes, we aim to make an impact that is sustainable into the future, giving new momentum to this global initiative."

The Minister of Health of Mexico City, Dr Armando Ahued Ortega, states that early detection of diabetes and care hereof are one of his administration's public health priorities.

"We have implemented large-scale initiatives to fight overweight, obesity and diabetes and we are starting to see the results. However, diabetes continues to constitute a heavy burden for the city's health services. I look forward to seeing the results from the research phase initiated today, as they will provide a solid foundation for developing an integrated response to tackle this public health emergency. I am very proud of Mexico City taking the global lead to fight urban diabetes."


'/>"/>

Contact: Henry Rummins
h.rummins@ucl.ac.uk
020-767-99063
University College London
Source:Eurekalert

Related biology news :

1. Novo Nordisk and BGI establish global collaboration framework
2. New international partnership aims to unlock wheats potential
3. JAX, UC Davis partner on shared research infrastructure, education initiatives
4. Iowa State Universitys Wintersteen talks partnerships at national science meeting
5. MRC funds BREATHE Africa partnership
6. EcoHealth Alliance and Bat Conservation International forge partnership to work on global bat conservation and public health issues
7. Argonne partners with Metropolitan Water Reclamation District to study Chicago River microbe population
8. Anglo-French partnership develops guidance on future management of English Channel
9. DHL and Panthera partner to conserve South Africas leopards
10. Bold new partnership launches to harness potential of data scientists and big data
11. NSF, with interagency and international partners, makes first round of grants to understand Arctic sustainability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2016)... , Nov. 21, 2016   Neurotechnology ... object recognition technologies, today announced that the MegaMatcher ... cards was submitted for the NIST Minutiae ... passed all the mandatory steps of the evaluation ... is a continuing test of fingerprint templates used ...
(Date:11/17/2016)... Market Watch: Primarily supported by ownership types; Private ... market is to witness a value of US$37.1 billion by ... Annual Growth Rate (CAGR) of 10.75% is foreseen from ... North America is not way behind ... at 9.56% respectively. Report Focus: The ...
(Date:11/16/2016)... , Nov. 16, 2016 Sensory ... experience and security for consumer electronics, and ... financial and retail industry, today announced a global ... convenient way to authenticate users of mobile banking ... TrulySecure™ software which requires no specialized ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... December 02, 2016 , ... ... pharmaceutical and biotechnology companies dedicated to collaboratively developing improved chemistry, manufacturing and ... a vendor-supported, portable online UHPLC, with robust, probe-based sampling. , Online ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected ... of 7.3% during the forecast period of 2016 to 2021 dominated ... accounted for the largest share of immunohistochemistry (IHC) market, by end ... , , ... market spread across 225 pages, profiling 10 companies and supported with ...
(Date:11/30/2016)...  GenomOncology today announced the appointment of Joshua F. ... Dr. Coleman will oversee clinical content development and ... The GenomOncology software suite empowers molecular pathologists with a seamless ... decision support, from quality control through reporting. ... , , ...
(Date:11/30/2016)... , Nov. 30, 2016 Biotest Pharmaceuticals ... is pleased to announce the addition of its newest ... Kearney, Nebraska . The 15,200 square foot ... November 29th, 2016 and brings the total number of ... Ileana Carlisle , BPC,s Chief Executive Officer said ...
Breaking Biology Technology: